You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bromodomain-containing protein (BRD) inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Arterial Hypertension Trial in Calgary, Quebec City (Apabetalone)

Completed
  • Pulmonary Arterial Hypertension
  • Calgary, Alberta, Canada
  • +1 more
Apr 22, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 17, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)

Recruiting
  • Solid Tumor, Childhood
  • +2 more
  • Boston, Massachusetts
  • +5 more
Dec 27, 2022

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Relapsed Ewing Sarcoma Trial in Worldwide (INCB059872)

Terminated
  • Relapsed Ewing Sarcoma
  • Los Angeles, California
  • +10 more
Jul 14, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Trial in Houston (Azacitidine, BRD4

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 19, 2020

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate

Not yet recruiting
  • Cancer of Cervix
  • Apoptosis
  • Immunohistochemistry
  • (no location specified)
Nov 17, 2023

Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 3, 2023

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Squamous Cell Lung Cancer Trial in United States (ZEN003694)

Recruiting
  • Squamous Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Nov 1, 2022

Advanced Malignant Tumors Trial in Guangzhou, Hangzhou (TQB3617)

Recruiting
  • Advanced Malignant Tumors
  • Guangzhou, Guangdong, China
  • +1 more
Feb 11, 2022

Multiple Myeloma Trial in Australia, United Kingdom, United States (RO6870810, daratumumab)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +11 more
Feb 6, 2020

Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • +2 more
  • (no location specified)
Jul 18, 2023

Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Oct 31, 2023

Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)

Recruiting
  • Refractory Solid Tumor
  • 177Lu-DOTA-EB-FAPI radionuclide therapy
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Jul 26, 2023

Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)

Recruiting
  • Myocardial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
May 11, 2023

Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

Recruiting
  • Advanced Breast Cancer
  • TQB3909 tablets
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 16, 2023

Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)

Recruiting
  • Healthy Adults
  • Daytona Beach, Florida
    Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023